Edition:
United States

Stemline Therapeutics Inc (STML.OQ)

STML.OQ on NASDAQ Stock Exchange Capital Market

15.40USD
14 Aug 2018
Change (% chg)

-- (--)
Prev Close
$15.40
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
59,634
52-wk High
$20.55
52-wk Low
$7.30

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.67 December 15 Aug 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 2 2 2 2
(2) OUTPERFORM 3 3 3 2
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.60 1.60 1.60 1.50

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-18 5 0.04 0.20 0.00 0.15
Quarter Ending Dec-18 5 0.41 2.06 0.00 37.95
Year Ending Dec-18 5 0.96 2.80 0.50 35.59
Year Ending Dec-19 5 62.67 135.00 5.00 72.32
Earnings (per share)
Quarter Ending Sep-18 5 -0.67 -0.64 -0.71 -0.54
Quarter Ending Dec-18 5 -0.76 -0.65 -0.97 0.55
Year Ending Dec-18 5 -2.77 -2.63 -3.04 -0.99
Year Ending Dec-19 5 -0.91 1.54 -2.37 -0.15

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Jun-18 0.04 0.50 0.46 1,150.00
Quarter Ending Mar-18 0.05 0.00 0.05 100.00
Quarter Ending Dec-17 0.17 0.00 0.17 100.00
Quarter Ending Sep-17 0.17 0.30 0.13 79.36
Quarter Ending Jun-17 0.20 0.30 0.10 49.65

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-18 0.04 0.04 0.04 0.04 0.15
Quarter Ending Dec-18 0.41 0.41 0.41 0.41 37.95
Year Ending Dec-18 0.96 0.49 0.49 0.50 35.59
Year Ending Dec-19 62.67 62.59 62.59 62.57 72.32

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-18 0 0 0 0
Quarter Ending Dec-18 0 0 0 0
Year Ending Dec-18 5 0 5 0
Year Ending Dec-19 1 1 1 1
Earnings